Diabetes Care Devices Market Landscape 2025: Forecast Data and Growth Strategy Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Diabetes Care Devices Market Through 2025?
In recent times, there has been a swift expansion in the size of the diabetes care devices market. The market, worth $66.46 billion in 2024, is projected to ascend to $73.91 billion in 2025, growing at a compound annual growth rate (CAGR) of 11.2%. The surge in growth during the historic period can be credited to factors such as a rise in diabetes cases, economic expansion, improvements in public health insurance, increased elderly population, and boosted healthcare spending.

What's the Projected Size of the Global Diabetes Care Devices Market by 2029?
Expectations are high for a swift expansion of the diabetes care devices market in the forthcoming years, with projections indicating a growth to $115.94 billion by 2029, at a compound annual growth rate (CAGR) of 11.9%. Multiple factors will contribute to this growth during the forecast period, including increased investments in R&D, increased disease burden, government initiatives, and advancements in technology. A noteworthy trend in the forecast period would be the emergence of needle-free glucose testing, glucose-responsive insulins (GRIS), artificial pancreas, a shift away from traditional insulin syringes, the adoption of wearable and mobile glucose monitoring systems, and the rise of smart glucose meters.

View the full report here:
https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-global-market-report

Top Growth Drivers in the Diabetes Care Devices Industry: What's Accelerating the Market?
As healthcare costs continue to rise, it's projected this trend will fuel the expansion of the diabetes care device market. Healthcare expenses encompass the cumulative funds allocated to services, products, and activities associated with healthcare over a predetermined time frame, on scales varying from individual to global. With healthcare costs on the rise, along with enhanced accessibility to healthcare services and a spike in diabetes diagnoses, there's an increase in the money invested in research and development. This leads to the betterment of diabetes care devices, including advanced glucose monitoring systems, insulin delivery devices, and digital health platforms. For instance, Eurostat, a Europe-based government agency, reported in November 2023, that social protection spending on sickness and healthcare in the EU in 2022 accounted for 8.1% of GDP. Out of 24 EU nations, France had the highest spending at 10.0%, trailed by Germany at 9.7%. Bulgaria, on the other hand, had the lowest expense at 4.2%. Other nations with minimal spending encompassed Ireland (4.6%), Hungary and Lithuania (4.7%), and Estonia (4.8%). Therefore, growing healthcare expenditure is projected to drive the growth of the diabetes care device market in times to come.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3609&type=smp

Which Emerging Trends Are Transforming the Diabetes Care Devices Market in 2025?
The focus of prominent businesses in the diabetes care device market is on creating novel products, such as the Medtronic Extended Infusion, to boost their market profitability. The Medtronic Extended Infusion Set, which delivers insulin from the pump to the patient's body, is engineered to be worn for up to a week. Medtronic, a medical device company based in the US, introduced the Medtronic Extended infusion set in November 2022. The newly introduced infusion set employs cutting-edge materials designed to reduce the loss of insulin preservatives and improve flow, thereby extending its wear time. Its unique design features a newly developed tubing connector and a resilient adhesive patch, guaranteeing stable insulin levels and comfort for up to seven days.

What Are the Main Segments in the Diabetes Care Devices Market?
The diabetes care devices market covered in this report is segmented -

1) By Type: Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters
2) By Type of Expenditure: Public, Private
3) By Product: Instruments Or Equipment, Disposables
4) By Type Of Testing: Point Of Care (POC) Testing, Non-Point Of Care (POC) Testing
5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

Subsegments:
1) By Blood Glucose Test Strips: Standard Blood Glucose Test Strips, Test Strips for Continuous Glucose Monitors
2) By Insulin Pens: Pre-filled Insulin Pens, Reusable Insulin Pens, Smart Insulin Pens
3) By Syringes: Insulin Syringes (various capacities), Disposable Syringes, Safety Syringes
4) By Pumps and Injectors: Insulin Pumps, Insulin Jet Injectors, Patch Pumps
5) By Lancing Devices and Equipment: Manual Lancing Devices, Automatic Lancing Devices, Lancets (various gauges)
6) By Continuous Glucose Monitoring Devices and Equipment: Real-Time CGM Systems, Flash Glucose Monitoring Systems, CGM Sensors and Transmitters
7) By Blood Glucose Meters: Standard Blood Glucose Meters, Smart Blood Glucose Meters, Meters with Integrated Data Management

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3609&type=smp

Which Top Companies are Driving Growth in the Diabetes Care Devices Market?
Major companies operating in the diabetes care devices market include Becton Dickinson and Company, Roche Holding AG, Nipro Corporation, HTL-STREFA Inc., ARKRAY, Terumo Corporation, Owen Mumford, Ypsomed AG, Vogt Medical, Sanofi India, Biocon Ltd, Mehar healthcare, Johnson & Johnson, Shandong WeiGao Group Medical Polymer Company Limited, Yuwell medical equipment & supply Co, Medtronic, Emperra GmbH E-Health, Novo Nordisk A/S, Insujet, Eli Lilly, Fresenius Medical Care, Siemens, Stryker, Teleflex Medical, LifeScan, Ascensia Diabetes Care, Tandem Diabetes Care, Dexcom Inc., SocialDiabetes, Dottli, Themis Bioscience, Ok biotech, Acon Laboratories, Bayer AG, AgaMatrix.

Which Regions Will Dominate the Diabetes Care Devices Market Through 2029?
North America was the largest region in the global diabetes care devices market in 2024. Western Europe was the second largest region in the global diabetes care devices market. The regions covered in the diabetes care devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3609

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.